Figure 2.
YLZD alleviated oxidative stress damage and reduced NAFLD-related systemic inflammation. Liver homogenate levels of (A) T-AOC, (B) SOD, (C) GSH-Px, (D) ROS and (E) MDA, respectively. Serum levels of (F) TNF-α, (G) IL-6 and (H) IL-1β, respectively. Values are represented as mean ± SEM (n = 6 rats/group). ##p < 0.01 versus the Control group; **p < 0.01, *p < 0.05 versus the HFD group.
